IRIS
ZITO MARINO, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.797
NA - Nord America 3.345
AS - Asia 2.391
SA - Sud America 381
Continente sconosciuto - Info sul continente non disponibili 220
AF - Africa 51
OC - Oceania 5
Totale 12.190
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.835
US - Stati Uniti d'America 3.208
SG - Singapore 769
IT - Italia 706
IE - Irlanda 557
CN - Cina 451
HK - Hong Kong 448
BR - Brasile 324
VN - Vietnam 305
DE - Germania 180
GB - Regno Unito 151
KR - Corea 135
JP - Giappone 101
CA - Canada 88
UA - Ucraina 82
IN - India 69
FR - Francia 56
GR - Grecia 44
FI - Finlandia 39
AT - Austria 22
TR - Turchia 22
NL - Olanda 21
SE - Svezia 21
MX - Messico 17
AR - Argentina 16
ZA - Sudafrica 15
BE - Belgio 14
PL - Polonia 13
PK - Pakistan 12
CH - Svizzera 11
BD - Bangladesh 10
IQ - Iraq 10
MA - Marocco 10
EC - Ecuador 9
ES - Italia 9
PH - Filippine 9
CO - Colombia 8
CR - Costa Rica 8
PY - Paraguay 7
MK - Macedonia 6
VE - Venezuela 6
AU - Australia 5
BJ - Benin 5
CL - Cile 5
CZ - Repubblica Ceca 5
ID - Indonesia 5
SV - El Salvador 5
TH - Thailandia 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
BG - Bulgaria 4
SA - Arabia Saudita 4
TN - Tunisia 4
DK - Danimarca 3
DZ - Algeria 3
EG - Egitto 3
GT - Guatemala 3
HN - Honduras 3
JM - Giamaica 3
KE - Kenya 3
LT - Lituania 3
NP - Nepal 3
OM - Oman 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BS - Bahamas 2
EE - Estonia 2
GD - Grenada 2
IL - Israele 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MY - Malesia 2
NG - Nigeria 2
NO - Norvegia 2
PE - Perù 2
PR - Porto Rico 2
RO - Romania 2
RS - Serbia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
AG - Antigua e Barbuda 1
AL - Albania 1
AO - Angola 1
BF - Burkina Faso 1
BH - Bahrain 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GH - Ghana 1
HR - Croazia 1
IR - Iran 1
JO - Giordania 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
ML - Mali 1
PA - Panama 1
Totale 11.969
Salva come PNG Salva come JPEG
Città #
Moscow 1.456
Dublin 551
San Jose 501
Hong Kong 444
Singapore 376
Santa Clara 344
Ashburn 282
Chandler 263
Council Bluffs 196
Naples 154
Seoul 134
Jacksonville 133
Ho Chi Minh City 99
Beijing 79
Hanoi 73
Princeton 68
Roxbury 67
Dallas 62
Boardman 61
Munich 57
Hefei 54
New York 54
Milan 51
Bremen 46
Los Angeles 45
Bengaluru 41
Medford 38
Elora 37
São Paulo 34
Aversa 33
Cambridge 30
The Dalles 29
Caserta 27
Des Moines 23
Da Nang 21
Ercolano 21
Miano 21
Nuremberg 21
Wilmington 20
Napoli 18
Brooklyn 17
Chicago 17
Orem 16
San Francisco 16
Rome 15
Brussels 14
Haiphong 14
Warsaw 13
Atlanta 12
Frankfurt am Main 12
Memphis 12
Tokyo 12
Biên Hòa 11
Grumo Nevano 11
Montreal 10
Ninh Bình 10
North Bergen 10
Toronto 10
Vienna 10
Woodbridge 10
Amsterdam 9
Falkenstein 9
Rio de Janeiro 9
Seattle 9
Brasília 8
Columbus 8
Helsinki 8
Johannesburg 8
Lappeenranta 8
Shanghai 8
Stockholm 8
Düsseldorf 7
Mexico City 7
Portici 7
Tianjin 7
Afragola 6
Ann Arbor 6
Asunción 6
Belo Horizonte 6
Chennai 6
Kochi 6
London 6
Nanchang 6
Phoenix 6
Thái Nguyên 6
Volla 6
Ariano Irpino 5
Castellammare di Stabia 5
Changsha 5
Curitiba 5
Falls Church 5
Goiânia 5
Guangzhou 5
Houston 5
Hải Dương 5
Jinan 5
Manchester 5
San Giuliano 5
San Salvador 5
Tashkent 5
Totale 6.572
Salva come PNG Salva come JPEG
Nome #
Genital and Oral HPV Geno-Prevalence Measured through Urine and Saliva Samples in Young Adults in Italy 205
Adequacy of Cytologic Samples by Ultrasound-Guided Percutaneous Transthoracic Fine-Needle Aspiration Cytology of Peripheral Pulmonary Nodules for Morphologic Diagnosis and Molecular Evaluations: Comparison With Computed Tomography-Guided Percutaneous Transthoracic Fine-Needle Aspiration Cytology 205
Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis 197
Analysis of NSCLC tumour heterogeneity, proliferative and 18F-FDG PET indices reveals Ki67 prognostic role in adenocarcinomas 194
Microsatellite Status Detection in Gastrointestinal Cancers: PCR/NGS Is Mandatory in Negative/Patchy MMR Immunohistochemistry 190
Anaplastic lymphoma kinase: a glimmer of hope in lung cancer treatment? 186
Are tumor-infiltrating lymphocytes protagonists or background actors in patient selection for cancer immunotherapy? 176
AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer 173
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer 170
A Critical Issue in Lung Cancer Cytology and Small Biopsies: DNA and RNA Extraction from Archival Stained Slides for Biomarker Detection through Real Time PCR and NGS-The Experience in Pathological Anatomy Unit 170
A case of primary cutaneous B-cell lymphoma with immature features in an old man. Diffuse Large B-cell Lymhpoma with immature features or B-cell Lymhpoblastic Lymphoma? 169
Cytologic diagnosis of metastatic melanoma by FNA: A practical review 167
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte 161
Immunotherapy in Penile Squamous Cell Carcinoma: Present or Future? Multi-Target Analysis of Programmed Cell Death Ligand 1 Expression and Microsatellite Instability 160
Predictive biomarkers along gastric cancer pathogenetic pathways 160
Discrepancy of p16 immunohistochemical expression and HPV RNA in penile cancer. A multiplex in situ hybridization/immunohistochemistry approach study 159
AXL and MET Tyrosine Kinase Receptors Co-Expression as a Potential Therapeutic Target in Malignant Pleural Mesothelioma 158
Circulating tumor cells as emerging tumor biomarkers in lung cancer. 158
Variable levels of spike and ORF1ab RNA in post-mortem lung samples of SARS-CoV-2-positive subjects: comparison between ISH and RT-PCR 157
Microsatellite Instability: From the Implementation of the Detection to a Prognostic and Predictive Role in Cancers 157
Interventional cytopathology in COVID-19 ERA 155
Inherited predisposition to malignant mesothelioma: germline BAP1 mutations and beyond 151
The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis 149
Aberrant signaling through the HER2-ERK1/2 pathway is predictive of reduced disease-free and overall survival in early stage non-small cell lung cancer (NSCLC) patients 149
Cytological diagnosis of Xp11 translocation renal cell carcinoma: An unusual suspect in bone metastases from unknown primary malignancies 148
Implementation of BRCA mutations testing in formalin-fixed paraffin-embedded (FFPE) samples of different cancer types 147
Current treatment of cutaneous squamous cancer and molecular strategies for its sensitization to new target-based drugs. 147
The potential diagnostic and predictive role of anaplastic lymphoma kinase (ALK) gene alterations in melanocytic tumors 146
Analysis of microsatellite instability (MSI) in pediatric gonadal and extra-gonadal germ cell tumors 146
To Get the Most out of the Least: BRAF Molecular Evaluation in Melanoma Metastases on Cell Suspension from Fine Needle Aspiration Cytology Needle Rinses 145
A new look at the ALK gene in cancer: copy number gain and amplification 145
GOLPH3 promotes oncogenesis by controlling the intra-Golgi trafficking of glycosphingolipid synthases 145
PRAME Immunocytochemistry for the Diagnosis of Melanoma Metastases in Cytological Samples 144
HER2 EXPRESSION IN GASTROINTESTINAL TUMOR. A FOCUS ON DIAGNOSTIC ALGORITHM OF HER2. STATUS FROM GASTRIC TO INTESTINAL CANCER 143
Preliminary Experience of Liquid Biopsy in Lung Cancer Compared to Conventional Assessment: Light and Shadows 142
An Integrated In Silico, In Vitro and Tumor Tissues Study Identified Selenoprotein S (SELENOS) and Valosin-Containing Protein (VCP/p97) as Novel Potential Associated Prognostic Biomarkers in Triple Negative Breast Cancer 141
Application of CytoMatrix for the diagnosis of melanoma metastases on FNA cytology samples: Performance of a novel cell block method 138
Double-staining Immunohistochemistry Reveals in Malignant Pleural Mesothelioma the Coexpression of ERCC1 and RRM1 as a Frequent Biological Event Related to Poorer Survival 138
AXL, c-MET and VEGFR2 Tyrosine Kinase Receptors as Therapeutic Targets in Malignant Pleural Mesothelioma 137
Correction: Intratumor heterogeneity of ALK-rearrangements and homogeneity of EGFR-mutations in mixed lung adenocarcinoma 136
ALK Rearrangement in Lung Cancer: Is Patients Filtering Possible 135
Concomitant ALK/KRAS and ALK/EGFR mutations in non small cell lung cancer: Different profile of response to target therapies 134
Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma 134
Immunohistochemistry for Cancer Stem Cell Detection: Principles and Methods 133
Mesenchymal neoplasms: Is it time for cytology? New perspectives for the pre-operative diagnosis of soft tissue tumors in the molecular era 129
Unproductive Effects of ALK Gene Amplification and Copy Number Gain in Non-Small-Cell Lung Cancer. ALK Gene Amplification and Copy Gain in NSCLC 129
Second Diagnostic Opinion by Experienced Dermatopathologists in the Setting of a Referral Regional Melanoma Unit Significantly Improves the Clinical Management of Patients With Cutaneous Melanoma 129
Multiplex fluorescence in situ hybridisation to detect anaplastic lymphoma kinase and ROS proto-oncogene 1 receptor tyrosine kinase rearrangements in lung cancer cytological samples 128
The prognostic value of histopathology in invasive lung adenocarcinoma: a comparative review of the main proposed grading systems 127
MALT GASTRIC LYMPHOMA: AN UPDATE OF PATHOGENETIC FEATURES 127
Diagnostic accuracy of FNA cytology for diagnosis of salivary gland tumors in pediatric patients 126
Heterogeneity of PD-L1 Expression in Lung Mixed Adenocarcinomas and Adenosquamous Carcinomas 124
Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study 123
The value of ACR, European, Korean, and ATA ultrasound risk stratification systems combined with RAS mutations for detecting thyroid carcinoma in cytologically indeterminate and suspicious for malignancy thyroid nodules 122
Extragonadal germ cell tumors: Not just a matter of location. A review about clinical, molecular and pathological features 122
Intratumor heterogeneity of ALK-rearrangements and homogeneity of EGFR-mutations in mixed lung adenocarcinoma 121
Extrapleural solitary fibrous tumor: A distinct entity from pleural solitary fibrous tumor. An update on clinical, molecular and diagnostic features 120
Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC 119
Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma 119
Multiplex HPV RNA in situ hybridization/p16 immunohistochemistry: a novel approach to detect papillomavirus in HPV-related cancers. A novel multiplex ISH/IHC assay to detect HPV 119
PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant Phenotype 118
Detection of folate receptor-positive circulating tumor cells by ligand-targeted polymerase chain reaction in non-small cell lung cancer patients 118
COVID-19: detection methods in post-mortem samples 116
Combined blockade of mTOR and p21-activated kinases pathways prevents tumour growth in KRAS-mutated colorectal cancer 114
NTRK gene aberrations in triple-negative breast cancer: detection challenges using IHC, FISH, RT-PCR, and NGS 113
The contrasting role of p16Ink4A patterns of expression in neuroendocrine and non-neuroendocrine lung tumors: A comprehensive analysis with clinicopathologic and molecular correlations 113
The tumour suppressor CCDC6 is involved in ROS tolerance and neoplastic transformation by evading ferroptosis 112
How to Diagnose Anaplastic Large Cell Lymphoma on Cytological Samples? A Series with Emphasis on Diagnostic Clue and Pitfalls 110
New therapeutic perspectives in CCDC6 deficient lung cancer cells 110
Skin Adnexal Tumours: A Large Spectrum of Clinic-Pathological Lesions 110
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Syndrome and Carcinoid Tumors With/Without NECH: A Clinicopathologic, Radiologic, and Immunomolecular Comparison Study 110
CRISPR-barcoding in non small cell lung cancer: From intratumor genetic heterogeneity modeling to cancer therapy application 109
Fusion proteins in lung cancer: addressing diagnostic problems for deciding therapy 106
Crizotinib Response in a Late Relapse of ALK-positive Lung Adenocarcinoma 105
Mitochondrial AKAP1 supports mTOR pathway and tumor growth 105
Predictive Evaluation on Cytological Sample of Metastatic Melanoma: The Role of BRAF Immunocytochemistry in the Molecular Era 104
Primary and secondary cutaneous angiosarcoma: Distinctive clinical, pathological and molecular features 104
Immunohistochemistry for cancer stem cells detection: Principles and methods 103
The GOLPH3 oncogene controls the intra-Golgi recycling of sphingolipid glycosylating enzymes to promote proliferation 101
Diagnosis of anaplastic lymphoma kinase rearrangement in cytological samples through a fluorescence in situ hybridization-based assay: Cytological smears versus cell blocks 99
Nivolumab in heavily pretreated metastatic gastric cancer patients: Real-life data from a western population 99
The Role of Toll-like Receptor-4 in Macrophage Imbalance in Lethal COVID-19 Lung Disease, and Its Correlation with Galectin-3 95
Diagnostic performance of melanocytic markers for immunocytochemical evaluation of lymph-node melanoma metastases on cytological samples 94
Structural analysis of human SEPHS2 protein, a selenocysteine machinery component, over-expressed in triple negative breast cancer 93
RNAScope in situ Hybridization as a Novel Technique for the Assessment of c-KIT mRNA Expression in Canine Mast Cell Tumor 89
Multitarget fluorescence in situ hybridization diagnostic applications in solid and hematological tumors 88
NTRK Gene Fusion Detection in Atypical Spitz Tumors 88
Detection of ROSI rearrangement in non-small cell lung cancer: Current and future perspectives 78
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 78
Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: A multi-institutional research study 77
The Role of TLR-2 in Lethal COVID-19 Disease Involving Medullary and Resident Lung Megakaryocyte Up-Regulation in the Microthrombosis Mechanism 63
Current and potential immunohistochemical biomarkers for prognosis and therapeutic stratification of breast carcinoma 62
MTAP in small biopsy samples of pancreatic lesions: a potential diagnostic biomarker. Immunohistochemical, fluorescence in situ hybridization and molecular analysis 56
Ocular Melanoma: A Comprehensive Review with a Focus on Molecular Biology 39
BRCA1 and BRCA2 mutations testing in prostate cancer: Detection in formalin fixed paraffin embedded (FFPE) and blood samples 27
Totale 12.190
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.276
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.276
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022466 0 0 0 4 126 7 30 10 22 48 75 144
2022/20231.093 128 36 20 87 99 80 11 52 524 14 18 24
2023/2024502 44 27 25 33 145 41 20 17 12 11 45 82
2024/20251.686 24 19 12 34 301 235 268 174 232 193 124 70
2025/20266.639 285 396 296 288 555 3.568 365 317 206 202 110 51
2026/20271.137 53 132 468 484 0 0 0 0 0 0 0 0
Totale 12.190